These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8944429)

  • 1. Differential expression of CD44 splice variants in malignant and benign pleural effusions.
    Tojo N; Inase N; Ichioka M; Miyazato I; Nara N
    Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
    Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
    Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.
    Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H
    J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions.
    Sikora J; Dworacki G; Trybus M; Batura-Gabryel H; Zeromski J
    Tumour Biol; 1998; 19(3):196-204. PubMed ID: 9591046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
    Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
    Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the phenotype pattern of macrophages isolated from malignant and non-malignant pleural effusions.
    Kaczmarek M; Nowicka A; Kozłowska M; Zurawski J; Batura-Gabryel H; Sikora J
    Tumour Biol; 2011 Dec; 32(6):1123-32. PubMed ID: 21809139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 exon v6 is not implicated in the progression and metastasis of endometrial cancer.
    Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
    Cancer Lett; 1998 Mar; 125(1-2):221-5. PubMed ID: 9566719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells in malignant pleural effusions subsequent to lung carcinoma and their impact on the course of the disease.
    Budna J; Spychalski Ł; Kaczmarek M; Frydrychowicz M; Goździk-Spychalska J; Batura-Gabryel H; Sikora J
    Immunobiology; 2017 Mar; 222(3):499-505. PubMed ID: 27773662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer.
    Chen Y; Liang B; Zhao YJ; Wang SC; Fan YB; Wu GP
    Diagn Cytopathol; 2012 Apr; 40(4):287-91. PubMed ID: 22431315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 splicing isoforms in lung cancers: dominant expression of CD44v8-10 in non-small cell lung carcinomas.
    Sasaki JI; Tanabe KK; Takahashi K; Okamoto I; Fujimoto H; Matsumoto M; Suga M; Ando M; Saya H
    Int J Oncol; 1998 Mar; 12(3):525-33. PubMed ID: 9472088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
    Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
    Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
    Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
    Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human CD44v6 in non-small-cell lung cancer.
    Carbognani P; Spaggiari L; Romani A; Solli P; Corradi A; Cantoni AM; Petronini PG; Borghetti AF; Rusca M; Bobbio P
    Eur Surg Res; 1998; 30(6):403-8. PubMed ID: 9838232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 splice variants in metastatic and non-metastatic mouse tumour cell lines.
    Tkach T; Li E; Bestagno M; Burrone OR
    Immunol Lett; 1996 Sep; 52(2-3):81-7. PubMed ID: 8905400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression of the CD44 variant sharing exon v10 in renal cancer.
    Kan M; Aki M; Akiyama K; Naruo S; Kanayama H; Kagawa S
    Jpn J Cancer Res; 1995 Sep; 86(9):847-53. PubMed ID: 7591962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.